Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vives

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
The Journal of Rheumatology. Supplement|January 1, 1977
HLA antigens in Forestier's disease, ankylosing spondylitis, and polyarthrosis of the handsM G Ercilla, M A Brancos, Y Breysse, et al.
Lancet (London, England)|April 2, 1983
Clinically benign adult T-cell chronic lymphocytosis with unusual phenotypeT Gallart, I Anegón, S Woessner, et al.
Nucleic Acids Research|December 11, 1991
BglII and EcoRI polymorphism of the human nm23-H1 gene (NME1)J Yagüe, M Juan, A Leone, et al.
Occupational Medicine (Oxford, England)|April 18, 2007
Lung cancer mortality at a UK tin smelterS R Jones, P Atkin, C Holroyd, et al.
Leukemia Research|January 1, 1993
Isolation and characterisation of a CDw50 negative Jurkat T-cell line variant (PPL.1)F Lozano, L Places, J Alberola-Ila, et al.
European Journal of Immunology|April 12, 2001
Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinasesJ M Vilà, I Gimferrer, O Padilla, et al.
Biopolymers|June 1, 1992
Crystal structure of a helical oligopeptide model of polyglycine II and of other polyamides: acetyl-(glycyl-beta-alanyl)2-NH propylJ Tormo, J Puiggali, J Vives, et al.
Journal of Environmental Radioactivity|September 12, 2017
Approaches to modelling radioactive contaminations in forests - Overview and guidanceA Diener, P Hartmann, L Urso, et al.
Sangre|January 1, 1980
[Association of HLA-DR3 antigen to diseases with immunological components (author's transl)]F Arriaga, G Ercilla, A Pares, et al.
Blood|October 9, 1999
Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathwaysJ Esparza, C Vilardell, J Calvo, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
The Journal of Rheumatology. Supplement|January 1, 1977
HLA antigens in Forestier's disease, ankylosing spondylitis, and polyarthrosis of the handsM G Ercilla, M A Brancos, Y Breysse, et al.
Lancet (London, England)|April 2, 1983
Clinically benign adult T-cell chronic lymphocytosis with unusual phenotypeT Gallart, I Anegón, S Woessner, et al.
Nucleic Acids Research|December 11, 1991
BglII and EcoRI polymorphism of the human nm23-H1 gene (NME1)J Yagüe, M Juan, A Leone, et al.
Occupational Medicine (Oxford, England)|April 18, 2007
Lung cancer mortality at a UK tin smelterS R Jones, P Atkin, C Holroyd, et al.
Leukemia Research|January 1, 1993
Isolation and characterisation of a CDw50 negative Jurkat T-cell line variant (PPL.1)F Lozano, L Places, J Alberola-Ila, et al.
European Journal of Immunology|April 12, 2001
Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinasesJ M Vilà, I Gimferrer, O Padilla, et al.
Biopolymers|June 1, 1992
Crystal structure of a helical oligopeptide model of polyglycine II and of other polyamides: acetyl-(glycyl-beta-alanyl)2-NH propylJ Tormo, J Puiggali, J Vives, et al.
Journal of Environmental Radioactivity|September 12, 2017
Approaches to modelling radioactive contaminations in forests - Overview and guidanceA Diener, P Hartmann, L Urso, et al.
Sangre|January 1, 1980
[Association of HLA-DR3 antigen to diseases with immunological components (author's transl)]F Arriaga, G Ercilla, A Pares, et al.
Blood|October 9, 1999
Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathwaysJ Esparza, C Vilardell, J Calvo, et al.
Pageof 29